Oculoplastic Surgery Service, Department of Ophthalmology, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
Department of Ophthalmology, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
J Cosmet Dermatol. 2021 Sep;20(9):2758-2764. doi: 10.1111/jocd.13868. Epub 2020 Dec 19.
Facial care treatments have grown a remarkable demand for effective and minimally invasive techniques with fast recovery time. Plasma technology is a nonsurgical alternative technique for skin rejuvenation.
We assessed patient satisfaction and symptoms after upper eyelid blepharoplasty with plasma technology.
PATIENTS/METHODS: Observational study including 16 patients submitted to upper eyelid blepharoplasty using plasma technology to treat dermatochalasis. Patient satisfaction, symptoms, and quality of life were assessed using 2 questionnaires at follow-up days 7 and 30. Also, the answers were correlated with age, Fitzpatrick skin type, and quantity of eyelid skin treated with plasma.
All 16 patients were treated and completed the survey. Fourteen (87.5%) were female, and the mean age was 50.5 years. Physical appearance was the most relevant factor impacting on quality of life at first week postoperative. Regarding satisfaction with results, most patients stated higher level of satisfaction at day 7 follow-up analysis (P = .038). Less impact on quality of life and higher satisfaction was associated with eyelid-treated area (P = .044 and P = .036) and Fitzpatrick skin type (P = .043) at 7 and 30 days after procedure, respectively. Eyelid edema and itching were the symptoms most reported at 7 and 30 days, respectively.
Upper blepharoplasty with plasma is a minimally invasive treatment with low impact on quality of life. However, overall patient satisfaction is questionable when considering less willing of undergoing procedure again and decreased expectation with results over postoperative period. Symptoms are reported mainly at the first week after procedure.
面部护理治疗对有效且微创、恢复时间短的技术需求显著增长。等离子技术是一种非手术的皮肤年轻化替代技术。
我们评估了等离子技术在上眼睑成形术中的患者满意度和术后症状。
患者/方法：本研究为观察性研究，纳入 16 例接受等离子技术治疗皮肤松弛症的上眼睑成形术患者。使用 2 份问卷在术后第 7 天和第 30 天评估患者满意度、症状和生活质量。同时，还将这些答案与年龄、Fitzpatrick 皮肤类型和等离子处理的眼睑皮肤量相关联。
16 例患者均接受治疗并完成了调查。其中 14 例（87.5%）为女性，平均年龄为 50.5 岁。术后第 1 周，外观是影响生活质量的最重要因素。关于对结果的满意度，大多数患者在第 7 天随访分析时表示满意度更高（P=.038）。对生活质量影响较小和满意度较高与眼睑治疗面积（P=.044 和 P=.036）和手术 7 天和 30 天后的 Fitzpatrick 皮肤类型（P=.043）相关。术后第 7 天和第 30 天报告最多的症状分别为眼睑肿胀和瘙痒。
等离子上眼睑成形术是一种微创治疗方法，对生活质量的影响较小。然而，考虑到患者对再次接受手术的意愿降低以及术后对结果的期望降低，总体患者满意度存在疑问。症状主要发生在术后第 1 周。
